Your browser doesn't support javascript.
loading
A framework for assessing interactions for risk stratification models: the example of ovarian cancer.
Phung, Minh Tung; Lee, Alice W; McLean, Karen; Anton-Culver, Hoda; Bandera, Elisa V; Carney, Michael E; Chang-Claude, Jenny; Cramer, Daniel W; Doherty, Jennifer Anne; Fortner, Renee T; Goodman, Marc T; Harris, Holly R; Jensen, Allan; Modugno, Francesmary; Moysich, Kirsten B; Pharoah, Paul D P; Qin, Bo; Terry, Kathryn L; Titus, Linda J; Webb, Penelope M; Wu, Anna H; Zeinomar, Nur; Ziogas, Argyrios; Berchuck, Andrew; Cho, Kathleen R; Hanley, Gillian E; Meza, Rafael; Mukherjee, Bhramar; Pike, Malcolm C; Pearce, Celeste Leigh; Trabert, Britton.
Affiliation
  • Phung MT; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA.
  • Lee AW; Department of Public Health, California State University, Fullerton, Fullerton, CA, USA.
  • McLean K; Department of Gynecologic Oncology and Department of Pharmacology & Therapeutics, Elm & Carlton Streets, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Anton-Culver H; Department of Medicine, University of California, Irvine, Irvine, CA, USA.
  • Bandera EV; Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Carney ME; Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
  • Chang-Claude J; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Cramer DW; Cancer Epidemiology Group, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Doherty JA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Fortner RT; Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Goodman MT; Huntsman Cancer Institute, Department of Population Health Sciences, University of Utah, Salt Lake City, UT, USA.
  • Harris HR; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Jensen A; Department of Research, Cancer Registry of Norway, Oslo, Norway.
  • Modugno F; Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Moysich KB; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Pharoah PDP; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Qin B; Department of Epidemiology, University of Washington School of Public Health, Seattle, WA, USA.
  • Terry KL; Department of Lifestyle, Reproduction and Cancer, Danish Cancer Society Research Center, Copenhagen, Denmark.
  • Titus LJ; Women's Cancer Research Center, Magee-Women's Research Institute and Hillman Cancer Center, Pittsburgh, PA, USA.
  • Webb PM; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Wu AH; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburg, PA, USA.
  • Zeinomar N; Division of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
  • Ziogas A; Department of Computational Biomedicine, Cedars-Sinai Medical Centre, Los Angeles, CA, USA.
  • Berchuck A; Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Cho KR; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
  • Hanley GE; Department of Obstetrics and Gynecology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Meza R; Public Health, Muskie School of Public Service, University of Southern Maine, Portland, ME, USA.
  • Mukherjee B; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.
  • Pike MC; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
  • Pearce CL; Cancer Epidemiology and Health Outcomes, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Trabert B; Department of Medicine, University of California, Irvine, Irvine, CA, USA.
J Natl Cancer Inst ; 115(11): 1420-1426, 2023 11 08.
Article in En | MEDLINE | ID: mdl-37436712
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Female / Humans Language: En Journal: J Natl Cancer Inst Year: 2023 Document type: Article Affiliation country: Country of publication: